COMMUNIQUÉS West-GlobeNewswire
-
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
18/05/2026 -
Ipsen - Avril 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
18/05/2026 -
Letter to Shareholders from CEO Dr. Ryan Saadi
18/05/2026 -
Disclosure of transparency notifications from BlackRock, Inc.
18/05/2026 -
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
18/05/2026 -
Carbios annonce une évolution de sa gouvernance et la nomination de Benoît Grenot en qualité de Directeur Général.
18/05/2026 -
Capitol Hill Briefing To Spotlight Critical Health Care Services for Adults With Communication Disorders
18/05/2026 -
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
18/05/2026 -
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
18/05/2026 -
Arvinas Employees Give Back During Company-wide Impact Day
18/05/2026 -
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18/05/2026 -
Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer
18/05/2026 -
Red Ribbon Recovery Indiana reports strong patient outcomes in first year of operation
18/05/2026 -
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures
18/05/2026 -
Novo Nordisk A/S - share repurchase programme
18/05/2026 -
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study
18/05/2026 -
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
18/05/2026 -
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18/05/2026 -
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
18/05/2026
Pages